UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology and treatment outcome of ANCA-associated vasculitis in South Korea: a nationwide, population-based cohort study

Clinical and experimental rheumatology, 2024-04

2024

Volltextzugriff (PDF)

One year in review 2021: systemic vasculitis

Clinical and Experimental Rheumatology, 2021-03, Vol.39 Suppl 129 (2), p.3-12

2021

Volltextzugriff (PDF)

Systemic vasculitis: one year in review 2024

Clinical and experimental rheumatology, 2024-04, Vol.42 (4), p.771

2024

Volltextzugriff (PDF)

Possible implication of intermolecular epitope spreading in the production of anti-glomerular basement membrane antibody in anti-neutrophil cytoplasmic antibody-associated vasculitis

Clinical and experimental rheumatology, 2022-05

2022

Volltextzugriff (PDF)

Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort

Clinical and experimental rheumatology, 2023-04, Vol.41 (4), p.856

2023

Volltextzugriff (PDF)

Impact of concurrent glomerulonephritis on outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis

Clinical and experimental rheumatology, 2024-04, Vol.42 (4), p.811

2024

Volltextzugriff (PDF)

Anti-neutrophil cytoplasmic antibody patterns can predict clinical relapse in ANCA-associated vasculitis: overall population and subgroups

Clinical and experimental rheumatology, 2023-04, Vol.41 (4), p.848

2023

Volltextzugriff (PDF)

A Canadian vasculitis patient-driven survey to highlight which prednisone-related side effects matter the most

Clinical and experimental rheumatology, 2023-04, Vol.41 (4), p.943

2023

Volltextzugriff (PDF)

Key considerations for modelling the long-term costs and benefits of treatments for ANCA-associated vasculitis

Clinical and experimental rheumatology, 2024-04, Vol.42 (4), p.782

2024

Volltextzugriff (PDF)

TIM-3 regulates the NETs-mediated dendritic cell activation in myeloperoxidase-ANCA-associated vasculitis

Clinical and Experimental Rheumatology, 2021-03, Vol.39 Suppl 129 (2), p.13-20

2021

Volltextzugriff (PDF)

Immunopathological features of myopathy associated with small-to-medium-sized vessel vasculitis and differences from autoimmune myositis

Clinical and experimental rheumatology, 2024-04, Vol.42 (4), p.786

2024

Volltextzugriff (PDF)

Pathogenesis and treatment of ANCA-associated vasculitides

Clinical and experimental rheumatology, 2015-07, Vol.33 (4 Suppl 92), p.S11

Kallenberg, Cees G M

2015

Volltextzugriff (PDF)

Subphenotypes of ANCA-associated vasculitis identified by latent class analysis

Clinical and Experimental Rheumatology, 2021-03, Vol.39 Suppl 129 (2), p.62-68

2021

Volltextzugriff (PDF)

Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life

Clinical and experimental rheumatology, 2016-05, Vol.34 (3 Suppl 97), p.S54

2016

Volltextzugriff (PDF)

Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis

Clinical and Experimental Rheumatology, 2021-03, Vol.39 Suppl 129 (2), p.107-113

2021

Volltextzugriff (PDF)

The role of a functional variant of TYK2 in vasculitides and infections

Clinical and experimental rheumatology, 2020-09, Vol.38 (5), p.949

2020

Volltextzugriff (PDF)

ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center

Clinical and experimental rheumatology, 2014-05, Vol.32 (3 Suppl 82), p.S41

2014

Volltextzugriff (PDF)

Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature

Clinical and experimental rheumatology, 2012-01, Vol.30 (1 Suppl 70), p.S130

2012

Volltextzugriff (PDF)

Analysis of risk factors associated with diffuse alveolar haemorrhage in patients with ANCA-associated vasculitis and construction of a risk prediction model using line graph

Clinical and experimental rheumatology, 2024-04, Vol.42 (4), p.864

2024

Volltextzugriff (PDF)

Detection of asymptomatic aortic involvement in ANCA-associated vasculitis using FDG PET/CT

Clinical and experimental rheumatology, 2013-01, Vol.31 (1 Suppl 75), p.S56

2013

Volltextzugriff (PDF)

The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients

Clinical and experimental rheumatology, 2009-05, Vol.27 (3), p.409

2009

Volltextzugriff (PDF)

Endothelial microparticles as a diagnostic aid in Churg-Strauss vasculitis-induced cardiomyopathy

Clinical and experimental rheumatology, 2008-05, Vol.26 (3 Suppl 49), p.S86

2008

Volltextzugriff (PDF)

Risk factors for relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: tools for treatment decisions?

Clinical and experimental rheumatology, 2004, Vol.22 (6 Suppl 36), p.S94

2004

Volltextzugriff (PDF)

Are ANCA-associated vasculitides inherited?

Clinical and experimental rheumatology, 2004, Vol.22 (6 Suppl 36), p.S1

2004

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical And Experimental Rheumatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Kollektion

Publisher website
(45)
MEDLINE
(42)

Menü

Weitere Dienste

Einstellungen

Epidemiology and treatment outcome of ANCA-associated vasculitis in South Korea: a nationwide, population-based cohort study

One year in review 2021: systemic vasculitis

The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV-patients

Systemic vasculitis: one year in review 2024

Possible implication of intermolecular epitope spreading in the production of anti-glomerular basement membrane antibody in anti-neutrophil cytoplasmic antibody-associated vasculitis

Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort

Impact of concurrent glomerulonephritis on outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis

Anti-neutrophil cytoplasmic antibody patterns can predict clinical relapse in ANCA-associated vasculitis: overall population and subgroups

A Canadian vasculitis patient-driven survey to highlight which prednisone-related side effects matter the most

Key considerations for modelling the long-term costs and benefits of treatments for ANCA-associated vasculitis

TIM-3 regulates the NETs-mediated dendritic cell activation in myeloperoxidase-ANCA-associated vasculitis

Immunopathological features of myopathy associated with small-to-medium-sized vessel vasculitis and differences from autoimmune myositis

Pathogenesis and treatment of ANCA-associated vasculitides

Subphenotypes of ANCA-associated vasculitis identified by latent class analysis

Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life

Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis

The role of a functional variant of TYK2 in vasculitides and infections

ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center

Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature

Analysis of risk factors associated with diffuse alveolar haemorrhage in patients with ANCA-associated vasculitis and construction of a risk prediction model using line graph

Detection of asymptomatic aortic involvement in ANCA-associated vasculitis using FDG PET/CT

The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients

Endothelial microparticles as a diagnostic aid in Churg-Strauss vasculitis-induced cardiomyopathy

Risk factors for relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: tools for treatment decisions?

Are ANCA-associated vasculitides inherited?

Aktive Filter

Suchergebnisse filtern